key: cord-0763392-h5lvk6k8
authors: Shan, Shi; Guangming, Li; Wei, Lei; Xuedong, Yang
title: Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19: case report and literature review
date: 2020-10-09
journal: Revista do Instituto de Medicina Tropical de Sao Paulo
DOI: 10.1590/s1678-9946202062076
sha: b1a5a3729e6760b290d6e55876971467ac6a48d2
doc_id: 763392
cord_uid: h5lvk6k8

Coronavirus Disease 2019 (COVID-19) has rapidly spread worldwide. Numerous studies have shown its typical and atypical CT findings. We report one COVID-19 patient who presented with a transient pneumothorax, spontaneous pneumomediastinum (SP), as well as subcutaneous emphysema during hospitalization. Chest CT andclinical findings were discussed, and a literature review is presented. The probable cause of SP in COVID-19 was alveolar damage. Once pneumothorax and SP were present, the patient should be carefully monitored to prevent respiratory deterioration, especially when lung lesions are severe.

Since the outbreak of Coronavirus Disease 2019 (COVID-19), it has quickly spread worldwide. Globally, people infected were more than 8.5 million and deaths are over 0.4 million on June 19 th , according to the Johns Hopkins University's COVID-19 map.

The common CT manifestations of COVID-19 include pure ground-glass opacities (GGO), GGO with reticular opacities, GGO with consolidation, as well as consolidations. Bilateral lung involvement is frequent, especially in the posterior parts and peripheral areas. Pleural effusion, pericardial effusion and lymphadenopathy are rarely seen [1] [2] [3] . Spontaneous pneumomediastinum (SP) and pneumothorax are extremely rare in COVID-19, up to now a total of eight cases have been reported in the literature [4] [5] [6] [7] [8] [9] [10] [11] . We have also found one COVID-19 patient who showed SP, pneumothorax, as well as subcutaneous emphysema during treatment.

A 67-year-old man who worked in Wuhan, Hubei Province, China, returned to Xiangyang city from Wuhan on January 19 th , 2020. Fever occurred since that day, and the highest temperature was 38.5 °C. The patient showed occasional cough, shortness of breathe after activity, without expectoration, obvious dyspneaand diarrhea. He had a 5-year history of hypertension and no other underlying diseases. On February 7 th 2020, a real-time reverse transcription-polymerase chain reaction (RT-PCR) for the COVID-19 was positive. Laboratory tests carried out on February 7 th showed that SpO2, blood oxygen saturation, lymphocyte ratio and lymphocyte count were decreased; on the contrary, C-reactive protein, Erythrocyte sedimentation rate, neutrophil count, neutrophil ratio and LDH were elevated; the liver test was also abnormal, and the tests results are shown in Table 1 .

Chest CT was performed on January 28 th 2020 (Figure 1 ), on February 5 th (Figure 2 ), on February 11 th ( Figure 3 ) and on March 3 rd (Figure 4 ), respectively. Typical CT manifestations were found in the initial images, which included bilateral GGO with reticular opacities predominantly located in the periphery on January 28 th ; bilateral lung lesions progressed on February Table 1 ). The pulmonary lesions were treated conservatively and by March 3 rd the CT images had totally regressed. Clinical treatment mainly included an antibiotic (Ceftazidime), an anti-viral (Arbidol), low-dose methylprednisolone intravenous drip therapy (1mg/kg), and symptomatic supportive therapy adjusted according to the clinical conditions. Low-flow nasal catheter at 3L/min of oxygen was used. No invasive ventilation was performed during the period of hospitalization. The patient was tested by RT-PCR for COVID-19 on March 4 th and March 5 th 2020 and both tests were negative. Informed consent was obtained from the patient.

SP refers to a pneumomediastinum occurring in circumstances other than traumatic or of iatrogenic origin 12 . This patient did not undergo any invasive ventilation or surgical procedures during hospitalization, so that the pneumomediastinum was spontaneous.

In a previous study, SP developed in 11.6% of SARS patients and appeared 19.6±4.6 days after the onset of symptoms 13 . The SP in the COVID-19 patient reported here was diagnosed 23 days after the onset of symptoms, which was similar to those in SARS patients. The pulmonary pathology of COVID-19 greatly resembles the one seen in SARS, showing diffuse alveolar damage, cellular fibromyositis exudates, evident desquamation of pneumocytes and hyaline membrane formation 14 . We believe that the possible causes of SP in COVID-19 were similar to those in SARS. The alveolar rupture as a consequence of severe diffuse alveolar damage 13 and episodes of coughing or Valsalva maneuver that increase the pressure in the chest as inducing factors, then causing interstitial emphysema, and air dissection along the bronchovascular sheaths into the mediastinum (SP) 15 . This can also help to explain why pneumothorax and subcutaneous emphysema occur simultaneously. In this case, pneumothorax and SP occurred after the progression of lung lesions (February 5 th ), suggesting that the occurrence of emphysema may be related to alveolar damage.

SP is generally a benign disease that may not need specific treatment and can be absorbed spontaneously. In the case reported here the SP was self-limited. SP, pneumothorax and subcutaneous emphysema were completely absorbed 21 days later. In SARS, high LDH level was associated with SP, and the development of SP was also associated with poor prognosis 13 . In this case, the maximum LDH was 384 U/L, considerably lower than the LDH levels in SP of SARS (LDH of 863 U/L) 13 . In the reported case, SP completely absorbed, and the patient's conditions improved and stabilized. Therefore, the relationship between SP and LDH elevation, and also with prognosis has yet to be further studied.

Recent literature has reported eight cases of SP and pneumothorax in COVID-19, M: F=5 : 3, the average age was 44.0±19.7 years, one of the patients eventually died and the other seven patients finally recovered after conservative treatment, needle decompression or catheter chest drainage. The patient who died had extremely severe lung lesions that progressed rapidly 8 (Table 2) . Therefore, the prognosis of SP and pneumothorax may be related to the severity of pulmonary lesions, but there is no clear correlation with the magnitude of pneumothorax and SP. As pneumothorax and SP are found, the patient should be carefully monitored to prevent respiratory deterioration, especially when the lung lesions are severe.

SP, pneumothorax and subcutaneous emphysema are extremely rare in COVID-19. The probable cause of SP in COVID-19 in the reported case was alveolar damage. SP and pneumothorax may be related to death when SP and pneumothorax are found, and the patient should be carefully monitored to prevent respiratory deterioration. Figure 4D , short arrow). Subcutaneous emphysema, SP and pneumothorax had been completely absorbed.

Coronavirus disease 2019 (COVID-19): a perspective from China

CT Imaging features of 2019 novel Coronavirus

Table 2 -Detailed description of patients with spontaneous pneumomediastinum and/or pneumothorax in COVID-19 in recent reports

Emerging 2019 novel Coronavirus (2019-nCoV) pneumonia

Spontaneous pneumomediastinum occurring in the SARS-COV-2 infection

e76 Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19

COVID-19 with spontaneous pneumomediastinum

COVID-19 with spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema

Spontaneous pneumomediastinum in COVID-19

Spontaneous pneumomediastinum: a probable unusual complication of Coronavirus disease 2019 (COVID-19) pneumonia

Spontaneous pneumothorax and subcutaneous emphysema in COVID-19 patient: case report

Tension pneumothorax in a patient with COVID-19

SARS-CoV-2 infection associated with spontaneous pneumothorax

Spontaneous pneumomediastinum: time for consensus

Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

The Macklin effect: a frequent etiology for pneumomediastinum in severe blunt chest trauma

Age